Evaluation of cystoprostatectomy on patients with prostate cancer extending to bladder: a retrospective study from single center

Evaluation of cystoprostatectomy on patients with prostate cancer extending to bladder: a retrospective study from single center

Abstract Background This is an exploratory research of cystoprostatectomy (CP) in treating prostate cancer (PCa) extending to the bladder, which aimed to evaluate the effects of CP on survival outcomes and improving quality of life (QoL) in these patients. Methods A total of 27 PCa patients extendin...

Full description

Bibliographic Details
Main Authors:	Xiaoliang Sun, Min Liu, Yong Zhao, Kang Leng, Haiyang Zhang
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Series:	BMC Urology
Subjects:	Cystoprostatectomy Prostate cancer Prostate cancer-specific survival Quality of life
Online Access:	https://doi.org/10.1186/s12894-022-01068-7

Similar Items

Incidental Prostate Cancer in Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer
by: Mustafa Hiroš, et al.
Published: (2008-05-01)

Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: A multicenter retrospective analysis
by: Berat Cem Özgür, et al.
Published: (2014-07-01)

Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens
by: Vuruskan Hakan, et al.
Published: (2011-07-01)

Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival
by: Joshua B. Kaelberer, et al.
Published: (2016-09-01)

Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis
by: Lucio Dell’Atti
Published: (2015-03-01)

Hyaluronic Acid Rectal Spacer for Rectal Protection in Salvage Cystoprostatectomy
by: Benjamin Ngie Xiong Wong, et al.
Published: (2025-02-01)

Multimodal therapy including robot‐assisted radical cystoprostatectomy for locally advanced prostate cancer with bladder and ureteral invasion: A case report
by: Masayoshi Okumi, et al.
Published: (2022-09-01)

Long‐term oncological outcomes after multimodal treatment for locally advanced prostate cancer
by: Fiorella L. Roldan, et al.
Published: (2024-09-01)

Clear cell adenocarcinoma of the prostatic urethra with metachronous prostate adenocarcinoma
by: Henry Wang, et al.
Published: (2023-03-01)

Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis
by: Mykyta Kachanov, et al.
Published: (2022-12-01)

Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer in the Department of Urology in a Tertiary Care Centre
by: Prashant Mishra, et al.
Published: (2023-10-01)

Prostatic stromal sarcoma – Management course of a rare presentation: A case report
by: Fahmi M. Salih, et al.
Published: (2023-03-01)

Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients
by: In-Chang Cho, et al.
Published: (2015-06-01)

Basal Cell Carcinoma of the Prostate Misdiagnosed as High-Grade Urothelial Cancer – A Case Report of a Diagnostic Pitfall
by: Taskovska M, et al.
Published: (2023-06-01)

Prevalence and Pathological Analysis of Adenocarcinoma Prostate Discovered Incidentally in Radical Cystoprostatectomy Specimen: An Indian Center Experience
by: Rajat Mahadik, et al.
Published: (2018-06-01)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
by: Dan Bee Lee, et al.
Published: (2023-01-01)

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation
by: Heikki Seikkula, et al.
Published: (2020-03-01)

Association of prostate volume with incidence and aggressiveness of prostate cancer
by: Al-Khalil S, et al.
Published: (2016-10-01)

Reporting Complications in Radical Cystoprostatectomy and Orthotopic Neobladder in Male Patients Using a Standard Reporting Methodology
by: Orkunt Özkaptan, et al.
Published: (2020-03-01)

The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics—Real-world Evidence from 2018 to 2022
by: Thorgerdur Palsdottir, et al.
Published: (2024-03-01)

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
by: David Thurtle, et al.
Published: (2020-06-01)

Outcomes and complications after transrectal ultrasound-guided prostate biopsy: A single-center study involving 425 consecutive patients
by: Jhen-Hao Jhan, et al.
Published: (2018-01-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

Non-muscle invasive micropapillary urothelial carcinoma of the bladder: Variable use of initial cystectomy versus intravesical bacillus calmette-guérin
by: Karishma Gupta, et al.
Published: (2021-12-01)

Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels
by: Kyo Chul Koo, et al.
Published: (2015-03-01)

Epidemiological Study of Patients with Prostate Cancer in South of Iraq
by: Manal Badi Salih Al-Tmemi
Published: (2019-07-01)

Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 Patients
by: Menachem Laufer, et al.
Published: (2023-09-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION
by: P. D. Demeshko, et al.
Published: (2015-09-01)

Testosterone levels at diagnosis: A key predictor of overall survival among patients with prostate cancer
by: Ilkka Jussila, et al.
Published: (2025-02-01)

Research of the best screen interval for middle aged and elderly Chinese males with baseline prostate specific antigen levels <2.0 ng/mL in prostate cancer screening
by: Yu Chen, et al.
Published: (2024-09-01)

The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?
by: Deepak Dubey
Published: (2009-01-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Effect of Glison index on survival of patients with localized prostate cancer in Samara region
by: R. D. Andreeva, et al.
Published: (2022-05-01)

Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer
by: Weitao Song, et al.
Published: (2015-01-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
by: Youngjun Boo, et al.
Published: (2023-07-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

Effect of Antibiotic on Men with Raised Prostatic-Specific Antigen (4-10 ng/ml)
by: Abdulsattar J. Ali, et al.
Published: (2020-12-01)